Financing Roundup: Immunomedics, Ardelyx, Millendo, Omeros, Athenex

Since market close on Wednesday, Immunomedics, Ardelyx, Millendo and Omeros raised a total of $450 million in follow-ons, while Athenex raised $60 million via a private placement.

Immunomedics Inc. (NASDAQ:IMMU) raised $250 million on Wednesday, pricing 14.3 million shares at $17.50 share, a discount of 8% to the stock’s close on Tuesday, before the offering was proposed. Underwriters were Goldman Sachs, BofA Securities, and Jefferies. On Tuesday, Immunomedics said it had resubmitted a BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer in a third-line setting...